Colin Watts - Publications

2006-2009 Brain Repair Centre University of Cambridge, Cambridge, England, United Kingdom 

68 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Maxan A, Mason S, Saint-Pierre M, Smith E, Ho A, Harrower T, Watts C, Tai Y, Pavese N, Savage JC, Tremblay MÈ, Gould P, Rosser AE, Dunnett SB, Piccini P, et al. Outcome of cell suspension allografts in a patient with Huntington's disease. Annals of Neurology. PMID 30286516 DOI: 10.1002/ana.25354  1
2016 Ma R, Watts C. Selective 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in Gliomas. Acta Neurochirurgica. PMID 27496021 DOI: 10.1007/s00701-016-2897-y  1
2016 Watts C, Sanai N. Surgical approaches for the gliomas. Handbook of Clinical Neurology. 134: 51-69. PMID 26948348 DOI: 10.1016/B978-0-12-802997-8.00004-9  1
2015 Piccirillo SG, Sottoriva A, Watts C. The role of sub-ventricular zone in gliomagenesis. Aging. 7: 738-9. PMID 26527608  1
2015 Maus F, Sakry D, Binamé F, Karram K, Rajalingam K, Watts C, Heywood R, Krüger R, Stegmüller J, Werner HB, Nave KA, Krämer-Albers EM, Trotter J. The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2. Plos One. 10: e0137311. PMID 26340347 DOI: 10.1371/journal.pone.0137311  1
2015 Ahmed SU, Carruthers R, Gilmour L, Yildirim S, Watts C, Chalmers AJ. Selective inhibition of parallel DNA damage response pathways optimizes radiosensitization of glioblastoma stem-like cells. Cancer Research. PMID 26282173 DOI: 10.1158/0008-5472.CAN-14-3790  1
2015 Rasul FT, Watts C. Novel Surgical Approaches to High-Grade Gliomas. Current Treatment Options in Neurology. 17: 369. PMID 26178621 DOI: 10.1007/s11940-015-0369-y  1
2015 Watts C. Clonal diversity in glioblastoma: is it clinically relevant? Future Oncology (London, England). 11: 1703-6. PMID 26075436 DOI: 10.2217/fon.15.73  1
2015 Kenney-Herbert E, Al-Mayhani T, Piccirillo SG, Fowler J, Spiteri I, Jones P, Watts C. CD15 Expression Does Not Identify a Phenotypically or Genetically Distinct Glioblastoma Population. Stem Cells Translational Medicine. 4: 822-31. PMID 26019225 DOI: 10.5966/sctm.2014-0047  1
2015 Piccirillo SG, Colman S, Potter NE, van Delft FW, Lillis S, Carnicer MJ, Kearney L, Watts C, Greaves M. Genetic and functional diversity of propagating cells in glioblastoma. Stem Cell Reports. 4: 7-15. PMID 25533637 DOI: 10.1016/j.stemcr.2014.11.003  1
2015 Piccirillo SG, Spiteri I, Sottoriva A, Touloumis A, Ber S, Price SJ, Heywood R, Francis NJ, Howarth KD, Collins VP, Venkitaraman AR, Curtis C, Marioni JC, Tavaré S, Watts C. Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone. Cancer Research. 75: 194-202. PMID 25406193 DOI: 10.1158/0008-5472.CAN-13-3131  1
2015 Carruthers R, Ahmed SU, Strathdee K, Gomez-Roman N, Amoah-Buahin E, Watts C, Chalmers AJ. Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase. Molecular Oncology. 9: 192-203. PMID 25205037 DOI: 10.1016/j.molonc.2014.08.003  1
2014 Setua S, Ouberai M, Piccirillo SG, Watts C, Welland M. Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma. Nanoscale. 6: 10865-73. PMID 25117686 DOI: 10.1039/c4nr03693j  1
2014 Watts C, Price SJ, Santarius T. Current concepts in the surgical management of glioma patients. Clinical Oncology (Royal College of Radiologists (Great Britain)). 26: 385-94. PMID 24882149 DOI: 10.1016/j.clon.2014.04.001  1
2014 Ajaz M, Jefferies S, Brazil L, Watts C, Chalmers A. Current and investigational drug strategies for glioblastoma Clinical Oncology. 26: 419-430. PMID 24768122 DOI: 10.1016/j.clon.2014.03.012  1
2014 Palfi S, Gurruchaga JM, Ralph GS, Lepetit H, Lavisse S, Buttery PC, Watts C, Miskin J, Kelleher M, Deeley S, Iwamuro H, Lefaucheur JP, Thiriez C, Fenelon G, Lucas C, et al. Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. Lancet. 383: 1138-46. PMID 24412048 DOI: 10.1016/S0140-6736(13)61939-X  1
2013 Walker D, Hamilton W, Walter FM, Watts C. Strategies to accelerate diagnosis of primary brain tumors at the primary-secondary care interface in children and adults. Cns Oncology. 2: 447-62. PMID 25054667 DOI: 10.2217/cns.13.36  1
2013 Antoniades CA, Watts C. Huntington's disease and cell therapies: past, present, and future. Methods in Molecular Biology (Clifton, N.J.). 1010: 19-32. PMID 23754216 DOI: 10.1007/978-1-62703-411-1_2  1
2013 Jefferies SJ, Harris FP, Price SJ, Collins VP, Watts C. High grade glioma--the arrival of the molecular diagnostic era for patients over the age of 65 years in the UK. Clinical Oncology (Royal College of Radiologists (Great Britain)). 25: 391-3. PMID 23615180 DOI: 10.1016/j.clon.2013.03.005  1
2013 Stricker SH, Feber A, Engström PG, Carén H, Kurian KM, Takashima Y, Watts C, Way M, Dirks P, Bertone P, Smith A, Beck S, Pollard SM. Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner. Genes & Development. 27: 654-69. PMID 23512659 DOI: 10.1101/gad.212662.112  1
2013 Sottoriva A, Spiteri I, Piccirillo SG, Touloumis A, Collins VP, Marioni JC, Curtis C, Watts C, Tavaré S. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proceedings of the National Academy of Sciences of the United States of America. 110: 4009-14. PMID 23412337 DOI: 10.1073/pnas.1219747110  1
2013 Barker RA, Mason SL, Harrower TP, Swain RA, Ho AK, Sahakian BJ, Mathur R, Elneil S, Thornton S, Hurrelbrink C, Armstrong RJ, Tyers P, Smith E, Carpenter A, Piccini P, ... ... Watts C, et al. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 657-65. PMID 23345280 DOI: 10.1136/jnnp-2012-302441  1
2013 Watts C, Dunn L, Ashkan K, Jenkinson M, Smith P. Establishing the efficacy of Gliadel wafers: progress towards a Phase III trial. Acta Neurochirurgica. 155: 61-2. PMID 23108559 DOI: 10.1007/s00701-012-1533-8  1
2013 Mair R, Watts C. Anti-angiogenesis in glioblastoma: The clinical consequences of redundancy and evasion? Current Angiogenesis. 2: 126-134. DOI: 10.2174/2211552802666140128000111  1
2013 Ryan DJ, Watts C. In vitro models of brain cancer Emerging Concepts in Neuro-Oncology. 2147483647: 75-86. DOI: 10.1007/978-0-85729-458-6_5  1
2013 Watts C. Emerging concepts in neuro-oncology Emerging Concepts in Neuro-Oncology. 2147483647: 1-220. DOI: 10.1007/978-0-85729-458-6  1
2012 Watts C. Surgical management of high-grade glioma: a standard of care. Cns Oncology. 1: 181-92. PMID 25057866 DOI: 10.2217/cns.12.26  1
2012 Appel EA, Rowland MJ, Loh XJ, Heywood RM, Watts C, Scherman OA. Enhanced stability and activity of temozolomide in primary glioblastoma multiforme cells with cucurbit[n]uril. Chemical Communications (Cambridge, England). 48: 9843-5. PMID 22936104 DOI: 10.1039/c2cc35131e  1
2012 Watts C. Umbilical cord stem cells: the hidden swan in a family of ugly ducklings. Acta Neurochirurgica. 154: 1727. PMID 22752731 DOI: 10.1007/s00701-012-1430-1  1
2012 Piccirillo SG, Dietz S, Madhu B, Griffiths J, Price SJ, Collins VP, Watts C. Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin. British Journal of Cancer. 107: 462-8. PMID 22722315 DOI: 10.1038/bjc.2012.271  1
2012 Heywood RM, Marcus HJ, Ryan DJ, Piccirillo SG, Al-Mayhani TM, Watts C. A review of the role of stem cells in the development and treatment of glioma. Acta Neurochirurgica. 154: 951-69; discussion 9. PMID 22527576 DOI: 10.1007/s00701-012-1338-9  1
2012 Antoniades CA, Buttery P, FitzGerald JJ, Barker RA, Carpenter RH, Watts C. Deep brain stimulation: eye movements reveal anomalous effects of electrode placement and stimulation. Plos One. 7: e32830. PMID 22427894 DOI: 10.1371/journal.pone.0032830  1
2011 Al-Mayhani MT, Grenfell R, Narita M, Piccirillo S, Kenney-Herbert E, Fawcett JW, Collins VP, Ichimura K, Watts C. NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature. Neuro-Oncology. 13: 830-45. PMID 21798846 DOI: 10.1093/neuonc/nor088  1
2011 Guilfoyle MR, Weerakkody RA, Oswal A, Oberg I, Jeffery C, Haynes K, Kullar PJ, Greenberg D, Jefferies SJ, Harris F, Price SJ, Thomson S, Watts C. Implementation of neuro-oncology service reconfiguration in accordance with NICE guidance provides enhanced clinical care for patients with glioblastoma multiforme. British Journal of Cancer. 104: 1810-5. PMID 21610702 DOI: 10.1038/bjc.2011.153  1
2011 Borg N, Guilfoyle MR, Greenberg DC, Watts C, Thomson S. Serum albumin and survival in glioblastoma multiforme. Journal of Neuro-Oncology. 105: 77-81. PMID 21409514 DOI: 10.1007/s11060-011-0562-0  1
2011 Kenney-Herbert EM, Ball SL, Al-Mayhani TM, Watts C. Glioblastoma cell lines derived under serum-free conditions can be used as an in vitro model system to evaluate therapeutic response. Cancer Letters. 305: 50-7. PMID 21402437 DOI: 10.1016/j.canlet.2011.02.025  1
2010 Iovino M, Patani R, Watts C, Chandran S, Spillantini MG. Human stem cell-derived neurons: a system to study human tau function and dysfunction. Plos One. 5: e13947. PMID 21085657 DOI: 10.1371/journal.pone.0013947  1
2010 Demetriades AK, Demetriades CK, Watts C, Ashkan K. Brain-machine interface: the challenge of neuroethics. The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland. 8: 267-9. PMID 20709284 DOI: 10.1016/j.surge.2010.05.006  1
2009 Zhao JW, Raha-Chowdhury R, Fawcett JW, Watts C. Astrocytes and oligodendrocytes can be generated from NG2+ progenitors after acute brain injury: intracellular localization of oligodendrocyte transcription factor 2 is associated with their fate choice. The European Journal of Neuroscience. 29: 1853-69. PMID 19473238 DOI: 10.1111/j.1460-9568.2009.06736.x  1
2009 Fael Al-Mayhani TM, Ball SL, Zhao JW, Fawcett J, Ichimura K, Collins PV, Watts C. An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours. Journal of Neuroscience Methods. 176: 192-9. PMID 19215724 DOI: 10.1016/j.jneumeth.2008.07.022  1
2008 Clelland CD, Barker RA, Watts C. Cell therapy in Huntington disease. Neurosurgical Focus. 24: E9. PMID 18341412 DOI: 10.3171/FOC/2008/24/3-4/E8  0.72
2007 Joannides AJ, Webber DJ, Raineteau O, Kelly C, Irvine KA, Watts C, Rosser AE, Kemp PJ, Blakemore WF, Compston A, Caldwell MA, Allen ND, Chandran S. Environmental signals regulate lineage choice and temporal maturation of neural stem cells from human embryonic stem cells. Brain : a Journal of Neurology. 130: 1263-75. PMID 17472984 DOI: 10.1093/brain/awm070  1
2007 Ozen I, Galichet C, Watts C, Parras C, Guillemot F, Raineteau O. Proliferating neuronal progenitors in the postnatal hippocampus transiently express the proneural gene Ngn2. The European Journal of Neuroscience. 25: 2591-603. PMID 17466019 DOI: 10.1111/j.1460-9568.2007.05541.x  1
2006 Levine AM, Vigen C, Gravink J, Mack W, Watts CH, Liebman HA. Progressive prothrombotic state in women with advancing HIV disease Journal of Acquired Immune Deficiency Syndromes. 42: 572-577. PMID 16837864 DOI: 10.1097/01.qai.0000230320.78288.79  1
2005 Watts C, McConkey H, Anderson L, Caldwell M. Anatomical perspectives on adult neural stem cells. Journal of Anatomy. 207: 197-208. PMID 16185244 DOI: 10.1111/j.1469-7580.2005.00448.x  1
2003 Watts C, Donovan T, Gillard JH, Antoun NM, Burnstein R, Menon DK, Carpenter TA, Fryer T, Thomas DGT, Pickard JD. Evaluation of an MRI-Based Protocol for Cell Implantation in Four Patients with Huntington's Disease. Cell Transplantation. 12: 697-704. PMID 28858590 DOI: 10.3727/000000003108747316  0.32
2003 Watts C, Donovan T, Gillard JH, Antoun NM, Burnstein R, Menon DK, Carpenter TA, Fryer T, Thomas DG, Pickard JD. Evaluation of an MRI-based protocol for cell implantation in four patients with Huntington's disease. Cell Transplantation. 12: 697-704. PMID 14653617  1
2003 Donovan T, Fryer TD, Peña A, Watts C, Carpenter TA, Pickard JD. Stereotactic MR imaging for planning neural transplantation: A reliable technique at 3 Tesla? British Journal of Neurosurgery. 17: 443-449. PMID 14635750 DOI: 10.1080/02688690310001613844  1
2002 Rosser AE, Barker RA, Harrower T, Watts C, Farrington M, Ho AK, Burnstein RM, Menon DK, Gillard JH, Pickard J, Dunnett SB. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. Journal of Neurology, Neurosurgery, and Psychiatry. 73: 678-85. PMID 12438470 DOI: 10.1136/jnnp.73.6.678  1
2002 Trivedi RA, Watts C, Kirkpatrick PJ, Gillard JH. Multiple cerebral aneurysms and the Diamond-Blackfan syndrome [5] Journal of Neurology Neurosurgery and Psychiatry. 72: 678-679. PMID 11971069 DOI: 10.1136/jnnp.72.5.678  1
2000 Armstrong RJE, Watts C, Svendsen CN, Dunnett SB, Rosser AE. Survival, Neuronal Differentiation, and Fiber Outgrowth of Propagated Human Neural Precursor Grafts in an Animal Model of Huntington's Disease. Cell Transplantation. 9: 55-64. PMID 28876110 DOI: 10.1177/096368970000900108  1
2000 Watts C, Brasted PJ, Dunnett SB. The morphology, integration, and functional efficacy of striatal grafts differ between cell suspensions and tissue pieces. Cell Transplantation. 9: 395-407. PMID 10972338  1
2000 Brasted PJ, Watts C, Torres EM, Robbins TW, Dunnett SB. Behavioral recovery after transplantation into a rat model of Huntington's disease: dependence on anatomical connectivity and extensive postoperative training. Behavioral Neuroscience. 114: 431-6. PMID 10832803 DOI: 10.1037//0735-7044.114.2.431  1
2000 Watts C, Dunnett SB. Towards a protocol for the preparation and delivery of striatal tissue for clinical trials of transplantation in Huntington's disease. Cell Transplantation. 9: 223-34. PMID 10811395  1
2000 Watts C, Brasted PJ, Dunnett SB. Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease. Experimental Neurology. 163: 85-97. PMID 10785447 DOI: 10.1006/exnr.1999.7341  1
2000 Watts C, McNamara IR, Dunnett SB. Volume and differentiation of striatal grafts in rats: relationship to the number of cells implanted. Cell Transplantation. 9: 65-72. PMID 10784068  1
2000 Armstrong RJ, Watts C, Svendsen CN, Dunnett SB, Rosser AE. Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. Cell Transplantation. 9: 55-64. PMID 10784067  1
2000 Eyre JA, Miller S, Clowry GJ, Conway EA, Watts C. Functional corticospinal projections are established prenatally in the human foetus permitting involvement in the development of spinal motor centres Brain. 123: 51-64. PMID 10611120  1
1999 Brasted PJ, Watts C, Torres EM, Robbins TW, Dunnett SB. Behavioural recovery following striatal transplantation: effects of postoperative training and P-zone volume. Experimental Brain Research. 128: 535-8. PMID 10541748 DOI: 10.1007/s002210050877  1
1999 Brasted PJ, Watts C, Robbins TW, Dunnett SB. Associative plasticity in striatal transplants. Proceedings of the National Academy of Sciences of the United States of America. 96: 10524-9. PMID 10468642 DOI: 10.1073/pnas.96.18.10524  1
1999 Gilligan JH, Welsh FKS, Watts C, Treasure T. Square pegs in round holes: Has psychometric testing a place in choosing a surgical career? A preliminary report of work in progress Annals of the Royal College of Surgeons of England. 81: 73-79. PMID 10364959  1
1998 Dunnett SB, Carter RJ, Watts C, Torres EM, Mahal A, Mangiarini L, Bates G, Morton AJ. Striatal transplantation in a transgenic mouse model of Huntington's disease. Experimental Neurology. 154: 31-40. PMID 9875265 DOI: 10.1006/exnr.1998.6926  1
1998 Watts C, Caldwell MA, Dunnett SB. The development of intracerebral cell-suspension implants is influenced by the grafting medium. Cell Transplantation. 7: 573-83. PMID 9853586 DOI: 10.1016/S0963-6897(98)00034-7  1
1998 Watts C, Dunnett SB. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: implications for timing of surgical intervention. Journal of Neurosurgery. 89: 267-74. PMID 9688122 DOI: 10.3171/jns.1998.89.2.0267  1
1997 Dunnett SB, Kendall AL, Watts C, Torres EM. Neuronal cell transplantation for Parkinson's and Huntington's diseases. British Medical Bulletin. 53: 757-76. PMID 9536526  1
1997 Watts C, Dunnett SB, Rosser AE. Effect of embryonic donor age and dissection on the DARPP-32 content of cell suspensions used for intrastriatal transplantation. Experimental Neurology. 148: 271-80. PMID 9398469 DOI: 10.1006/exnr.1997.6646  1
1997 Jolly PD, Smith PR, Heath DA, Hudson NL, Lun S, Still LA, Watts CH, McNatty KP. Morphological evidence of apoptosis and the prevalence of apoptotic versus mitotic cells in the membrana granulosa of ovarian follicles during spontaneous and induced atresia in ewes Biology of Reproduction. 56: 837-846. PMID 9096863 DOI: 10.1095/biolreprod56.4.837  1
1996 Gilligan JH, Treasure T, Watts C. Incorporating psychometric measures in selecting and developing surgeons Journal of Management in Medicine. 10: 5-16, 2. PMID 10538032  1
Show low-probability matches.